Policy

Venus Remedies receives Rs. 2.50 crore under PLI scheme

The company has now received 100% of the incentive owed to the company for the financial year 2022-23 under the PLI scheme

  • By IPP Bureau | April 01, 2024

Venus Remedies Ltd has been awarded with Rs. 2.50 crore under the Production Linked Incentive (PLI) scheme, which covers balance 25% of the total incentive of Rs.10.00 crores. The initial disbursement of Rs. 7.50 crore was awarded by the Central Government earlier this month.

Following the latest disbursement, Venus Remedies Ltd has now received 100% of the incentive owed to the company for the financial year 2022-23 under the PLI scheme.

This incentive further strengthens our commitment to innovation and excellence in pharmaceutical manufacturing.

Upcoming E-conference

ChemPharma R&D Summit 2026

October 27, 2026

Other Related stories

Startup

Digitization